| CIT | citrate; combined intermittent therapy; conjugated-immunoglobulin technique; crossed intrinsic trans... |
|---|---|
| conjug | conjugated, conjugation |
| ECE | equine conjugated estrogen |
| FCA | ferritin-conjugated antibodies; Freund's complete adjuvant; functional capacity assessment |
| AAPF | anti-arteriosclerosis polysaccharide factor |
| conjugated oestrogen | <pharmacology> An amorphous preparation of naturally occurring, water-soluble, conjugated forms of mixed oestrogen's obtained from the urine of pregnant mares; the principal oestrogen present is sodium estrone sulfate; suitable for parenteral, oral, and topical administration, and used in conditions responsive to oestrogen therapy. (05 Mar 2000) |
|---|---|
| conjugated protein | A protein that contains atleast one prosthetic group. (09 Oct 1997) |
| Strep-avidin conjugated horseradish peroxidase | <chemical> Synonym: sa-conjugated-hp, streptavidin conjugated horseradish peroxidase, strepavidin conjugated horseradish peroxidase (26 Jun 1999) |
| oestrogens, conjugated | An amorphous preparation containing water-soluble, conjugated forms of mixed oestrogens obtained from urine of pregnant mares. The principal oestrogen present is sodium estrone sulfate. The total oestrogenic potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate. (12 Dec 1998) |
| fluorescein-conjugated antibody | Refers to an antibody that has joined with a fluorescein molecule. (09 Oct 1997) |
| acellular vaccine | <immunology, pharmacology, virology> Vaccine consisting of antigenic parts of cells. (13 Nov 1997) |
| adjuvant vaccine | A vaccine that contains an adjuvant; most often the antigen (immunogen) is included in a water-in-oil emulsion (Freund incomplete type adjuvant), or is adsorbed onto an inorganic gel (alum, aluminum hydroxide or phosphate). (05 Mar 2000) |
| aqueous vaccine | A vaccine having a liquid vehicle (e.g., physiological salt solution) as distinguished from an emulsion. (05 Mar 2000) |
| attenuated vaccine | Live pathogens that have lost their virulence but are still capable of inducing a protective immune response to the virulent forms of the pathogen, e.g., Sabin polio vaccine. (05 Mar 2000) |
| autogenous vaccine | A vaccine made from a culture of the patient's own bacteria. (05 Mar 2000) |
| bacillus Calmette-Guerin vaccine | <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection. (15 Nov 1997) |
| BCG vaccine | <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection. (15 Nov 1997) |
| brucella strain 19 vaccine | A live bacterial vaccine prepared from an attenuated variant strain of Brucella abortus (strain 19); used for vaccinating cattle against brucellosis. (05 Mar 2000) |
| brucella vaccine | A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats. (12 Dec 1998) |
| Calmette-Guerin vaccine | <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection. (15 Nov 1997) |